# PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

> **NCT01617954** · — · COMPLETED · sponsor: **Agendia** · enrollment: 820 (actual)

## Conditions studied

- Hormone Receptor Positive Malignant Neoplasm of Breast

## Interventions

- **DEVICE:** MammaPrint

## Key facts

- **NCT ID:** NCT01617954
- **Lead sponsor:** Agendia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 820 (ACTUAL)
- **Last updated:** 2016-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01617954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01617954, "PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01617954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*